In the general population, chronic atrial fibrillation (AF) is a disease that most often occurs in
the elderly. The prevalence of AF is approximately 1% to 3% in the adult population, with a …

Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Its
increasing prevalence, particularly among the elderly, renders it one of the most serious current …

… Patients who are in atrial fibrillation for >48 hours are commonly anticoagulated for 3 to 4 …
discusses different treatment strategies for patients with atrial fibrillation. Atrial fibrillation (AF…

Although warfarin is superior to aspirin in reducing the risk of stroke in patients with atrial
fibrillation, it can increase major bleeds. Hence, physicians stratify patients according to stroke …

… Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in modern clinical practice,
with an estimated prevalence of 1.5–2%. The prevalence of AF is expected to double in the …

… Background and Purpose—Although the stroke rate associated with atrial fibrillation has
declined over the last 10 years, the emerging atrial fibrillation epidemic threatens to increase …

… arrhythmia, atrial fibrillation, and to develop better treatment strategies than previously
used… These efforts have resulted in further clarification of almost all aspects of this arrhythmia, …

… Another emerging anticoagulation strategy involves the use of the NOACs, including the …
are approved for systemic anticoagulation of patients with nonvalvular AF. The predictable …

… While atrial fibrillation is increasingly common in the elderly, … in atrial fibrillation among the
elderly are limited. When considering anticoagulation in the elderly patient with atrial fibrillation…

Most patients with atrial fibrillation need anticoagulant treatment with vitamin K antagonists
for prevention of thromboembolism, in particular ischemic stroke. Many studies show the …